Nektar Therapeutics Ownership | Who Owns Nektar Therapeutics?
Nektar Therapeutics Ownership Summary
Nektar Therapeutics is owned by 7.17% institutional investors, 1.31% insiders, and 91.52% retail investors. Blackrock is the largest institutional shareholder, holding 7.78% of NKTR shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 3.58% of its assets in Nektar Therapeutics shares.
NKTR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nektar Therapeutics | 7.17% | 1.31% | 91.52% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 15.16M | 7.78% | $18.79M |
| Blackrock funding, inc. /de | 16.09M | 7.69% | $14.97M |
| Vanguard group | 12.33M | 5.89% | $11.47M |
| Nantahala capital management | 7.79M | 3.69% | $5.30M |
| Acadian asset management | 7.20M | 3.44% | $6.69M |
| Eventide asset management | 6.65M | 3.18% | $6.18M |
| Primecap management co/ca/ | 5.54M | 2.65% | $5.15M |
| Woodline partners lp | 4.97M | 2.38% | $4.63M |
| Tcg crossover management | 4.00M | 1.91% | $3.72M |
| Geode capital management | 3.96M | 1.89% | $3.68M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Exome asset management | 2.23M | 1.35% | $1.52M |
| 22nw, lp | 2.19M | 1.29% | $2.04M |
| Altium capital management lp | 3.00M | 0.79% | $2.79M |
| Cm management | 750.00K | 0.62% | $697.50K |
| Union square park capital management | 1.10M | 0.49% | $748.00K |
| Tcg crossover management | 4.00M | 0.36% | $3.72M |
| Monaco asset management sam | 2.03M | 0.27% | $1.89M |
| Nantahala capital management | 7.79M | 0.21% | $5.30M |
| Almitas capital | 920.23K | 0.19% | $855.81K |
| Ikarian capital | 1.58M | 0.13% | $1.07M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 15.16M | 0.00% | 9.28M |
| Woodline partners lp | 4.97M | 0.03% | 3.24M |
| Altium capital management lp | 3.00M | 0.79% | 2.99M |
| State street | 2.99M | 0.00% | 2.30M |
| 22nw, lp | 2.19M | 1.29% | 2.19M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Samlyn capital | - | - | -9.67M |
| Stonepine capital management | - | - | -3.48M |
| Eventide asset management | 6.65M | 0.11% | -2.75M |
| Millennium management | 2.29M | 0.00% | -2.24M |
| Lynx1 capital management lp | - | - | -2.07M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| 22nw, lp | 2.19M | 1.29% | 2.19M | $2.04M |
| Union square park capital management | 1.10M | 0.49% | 1.10M | $748.00K |
| Cibc world markets | 16.71K | 0.00% | 16.71K | $15.54K |
| Xponance | 11.45K | 0.00% | 11.45K | $14.20K |
| Intellectus partners | 10.00K | 0.00% | 10.00K | $12.40K |
Sold Out
| Holder | Change |
|---|---|
| Cornerstone planning group | -5.00 |
| Assetmark | -22.00 |
| Cubist systematic strategies | -40.00 |
| Capital performance advisors llp | -66.00 |
| Princeton global asset management | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 8 | -94.59% | 15,114,671 | -88.63% | 7 | 0.18% | 2 | -97.14% | 4 | -88.89% |
| Dec 31, 2024 | 137 | -2.84% | 129,034,595 | -8.31% | 61 | 1.36% | 64 | 6.67% | 33 | -8.33% |
| Sep 30, 2024 | 141 | 3.68% | 140,729,035 | 3.96% | 67 | 1.39% | 61 | -15.28% | 36 | 5.88% |
| Jun 30, 2024 | 136 | 10.57% | 135,373,255 | 19.87% | 69 | 2.07% | 72 | 94.59% | 34 | -29.17% |
| Mar 31, 2024 | 123 | 0.82% | 112,937,953 | -5.21% | 57 | 1.47% | 37 | -11.90% | 48 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 6.65M | 3.58% | -2.75M |
| Vanguard US Total Market Shares ETF | 5.72M | 3.08% | - |
| Vanguard Total Stock Mkt Idx Inv | 5.72M | 3.08% | - |
| iShares Russell 2000 ETF | 4.72M | 2.53% | 2.31K |
| PRIMECAP Odyssey Aggressive Growth | 3.46M | 1.86% | -72.30K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.66M | 1.43% | - |
| Fidelity Small Cap Index | 1.79M | 0.96% | - |
| iShares Russell 2000 Value ETF | 1.67M | 0.90% | - |
| Vanguard Strategic Equity Inv | 1.52M | 0.82% | - |
| PRIMECAP Odyssey Growth | 1.37M | 0.73% | -78.90K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 19, 2025 | Zalevsky Jonathan | Chief R&D Officer | Sell | $7.18K |
| May 19, 2025 | Wilson Mark Andrew | Chief Legal Officer | Sell | $6.70K |
| May 19, 2025 | ROBIN HOWARD W | President & CEO | Sell | $15.55K |
| Feb 19, 2025 | Zalevsky Jonathan | Chief R&D Officer | Sell | $10.40K |
| Feb 19, 2025 | Wilson Mark Andrew | Chief Legal Officer | Sell | $11.15K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 3 |
| 2025 Q1 | - | 3 |
| 2024 Q4 | - | 8 |
| 2024 Q3 | - | 3 |
| 2024 Q2 | - | 5 |
NKTR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools